Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)
China · Delayed Price · Currency is CNY 17.73
-0.27 (-1.50%)
Jul 23, 2025, 2:45 PM CST
SHA:603079 Revenue
Zhejiang Shengda Bio-Pharm had revenue of 203.23M CNY in the quarter ending March 31, 2025, with 9.95% growth. This brings the company's revenue in the last twelve months to 845.80M, up 13.84% year-over-year. In the year 2024, Zhejiang Shengda Bio-Pharm had annual revenue of 827.40M with 13.75% growth.
Revenue (ttm)
845.80M
Revenue Growth
+13.84%
P/S Ratio
3.98
Revenue / Employee
817.20K
Employees
1,035
Market Cap
3.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 827.40M | 100.00M | 13.75% |
| Dec 31, 2023 | 727.41M | -10.61M | -1.44% |
| Dec 31, 2022 | 738.02M | -51.71M | -6.55% |
| Dec 31, 2021 | 789.73M | -77.58M | -8.95% |
| Dec 31, 2020 | 867.31M | 348.16M | 67.06% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |